Rituximab prophylaxis prevents corticosteroid-requiring chronic GVHD after allogeneic peripheral blood stem cell transplantation: results of a phase 2 trial

National Institutes of Health Chronic Graft-versus-Host Disease Staging in Severely Affected Patients: Organ and Global Scoring Correlate with Established Indicators of Disease Severity and Prognosis

(2013) Kristin Baird et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Increased BLNK and Syk in B Cells From Chronic Graft-Versus-Host Disease Patients: Identification of Novel Therapeutic Targets

(2013) Jessica L. Allen et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

CD19+CD21low B cells and patients at risk for NIH-defined chronic graft-versus-host disease with bronchiolitis obliterans syndrome

(2013) Z. Kuzmina et al.   BLOOD

Bone Marrow B cell Precursor Number after Allogeneic Stem Cell Transplantation and GVHD Development

(2012) Yuri Fedoriw et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence

(2012) S. Arai et al.   BLOOD

B cells from patients with chronic GVHD are activated and primed for survival via BAFF-mediated pathways

(2012) J. L. Allen et al.   BLOOD

A disease risk index for patients undergoing allogeneic stem cell transplantation

(2012) P. Armand et al.   BLOOD

Advances in Human B Cell Phenotypic Profiling

(2012) Denise A. Kaminski et al.   Frontiers in Immunology

Genetic variation in recipient B-cell activating factor modulates phenotype of GVHD

(2011) W. B. Clark et al.   BLOOD

Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans

(2011) M. Srinivasan et al.   BLOOD

Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium

(2011) J. Pidala et al.   BLOOD

Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria

(2011) S. Arai et al.   BLOOD

In vivo B-cell depletion with rituximab for alternative donor hemopoietic SCT

(2011) A Dominietto et al.   BONE MARROW TRANSPLANTATION

The global severity of chronic graft-versus-host disease, determined by National Institutes of Health consensus criteria, is associated with overall survival and non-relapse mortality

(2011) J. Pidala et al.   HAEMATOLOGICA

Rituximab Administration within 6 Months of T Cell-Depleted Allogeneic SCT is Associated with Prolonged Life-Threatening Cytopenias

(2010) Zachariah McIver et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Recovery of B-cell homeostasis after rituximab in chronic graft-versus-host disease

(2010) S. Sarantopoulos et al.   BLOOD

Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells

(2010) Y. Iwata et al.   BLOOD

Efficacy of Rituximab in the Setting of Steroid-Refractory Chronic Graft-versus-Host Disease: A Systematic Review and Meta-Analysis

(2009) Mohamed A. Kharfan-Dabaja et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Endpoints for Clinical Trials Testing Treatment of Acute Graft-versus-Host Disease: A Joint Statement

(2009) Paul J. Martin et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

The role of B cells in the pathogenesis of graft-versus-host disease

(2009) A. Shimabukuro-Vornhagen et al.   BLOOD

Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease

(2009) S. Sarantopoulos et al.   BLOOD

Standard graft-versus-host disease prophylaxis with or without anti-T-cell globulin in haematopoietic cell transplantation from matched unrelated donors: a randomised, open-label, multicentre phase 3 trial

(2009) Jürgen Finke et al.   LANCET ONCOLOGY

HLA-Haploidentical Bone Marrow Transplantation for Hematologic Malignancies Using Nonmyeloablative Conditioning and High-Dose, Posttransplantation Cyclophosphamide

(2008) Leo Luznik et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Rituximab as salvage therapy for refractory chronic GVHD

(2008) M Mohty et al.   BONE MARROW TRANSPLANTATION

B-cell involvement in chronic graft-versus-host disease

(2008) R. Kapur et al.   HAEMATOLOGICA